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Abstract 
The tightly regulated process of precursor messenger RNA (pre-mRNA) alternative 
splicing is a key mechanism to increase the number and complexity of proteins encoded 
by the genome. Evidence gathered in recent years has established that transcription and 
splicing are physically and functionally coupled and that this coupling may be an 
essential aspect of the regulation of splicing and alternative splicing. Recent advances in 
our understanding of transcription and of splicing regulation have uncovered the 
multiple interactions between components from both types of machinery. These 
interactions help to explain the functional coupling of RNAPII transcription and pre-
mRNA alternative splicing for efficient and regulated gene expression at the molecular 
level. Recent technological advances, in addition to novel cell and molecular biology 
approaches, have led to the development of new tools for addressing mechanistic 
questions to achieve an integrated and global understanding of the functional coupling 
of RNAPII transcription and pre-mRNA alternative splicing. Here, we review major 
milestones and insights into RNA polymerase II transcription and pre-mRNA 
alternative splicing as well as new concepts and challenges that have arisen from 
multiple genome-wide approaches and analyses at the single-cell resolution. 
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Introduction 
The expression of protein-coding genes in eukaryotes is a complex process that involves 
numerous tightly regulated steps. The genomic coding DNA sequence must be 
transcribed into a precursor messenger RNA (pre-mRNA) by the nuclear RNA 
polymerase II (RNAPII). The pre-mRNA must then undergo a number of processing 
steps to yield a mature, functional messenger RNA (mRNA), which is then ready to be 
exported from the nucleus and used by the translational machinery of the cell. Thus, 
RNA transcripts undergo extensive maturation in the nuclei of eukaryotic cells. The 
complexity of the processing that occurs during the formation of a mature mRNA 
provides a basis for the multilayered regulation of gene expression. These regulatory 
networks correlate with the organizational complexity of a given organism and with the 
specialization of tissues such as the components of the central nervous system and the 
cardiac muscle (Maniatis and Tasic, 2002; Mendes Soares and Valcarcel, 2006; 
Taliaferro et al., 2011). 
In higher eukaryotes, most protein-coding genes contain long non-coding stretches or 
intervening sequences (introns) that are transcribed in the pre-mRNA and must 
therefore be removed in a process called splicing, which leaves the resulting protein 
coding sequences (exons) appropriately aligned and ligated in the mRNA. The last 
decade has revealed the massive complexity and fundamental importance of this 
phenomenon in the regulation of gene expression. Splicing is a complex two-step trans-
esterification reaction that is driven by the spliceosome, which is a large 
ribonucleoprotein complex of five uridine-rich small nuclear RNAs (snRNAs) and 
approximately 200 additional proteins. Alternative splicing, the phenomenon by which 
a single pre-mRNA can be potentially spliced in multiple different patterns to yield two 
or more different mRNA products, contributes significantly to the diversity of cell and 
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tissue-specific protein expression profiles (Maniatis and Tasic, 2002). The results of 
deep sequencing-based expression analyses suggest that more than 90% of multi-exon 
human genes undergo alternative splicing (Pan et al., 2008; Wang et al., 2008). Changes 
in the cis- or trans- regulation of this process can cause multiple pathologies as a result 
of general or specific aberrant pre-mRNA processing underscoring the fundamental 
importance of this regulatory process. Several reviews covering dysfunctions related to 
mRNA processing have been published elsewhere (Caceres and Kornblihtt, 2002; 
Garcia-Blanco et al., 2004; Licatalosi and Darnell, 2006; Wang and Cooper, 2007). 
Although our understanding of how alternative splicing is controlled in the context of 
global gene expression regulation and its relevance in specific metabolic processes has 
greatly advanced during the last decade, the functional integration of pre-mRNA 
processing with other nuclear machineries is not yet well understood. 
It is widely accepted that transcription and splicing are physically and functionally 
coupled and that this coupling might be an important aspect of the regulation of splicing 
and alternative splicing. This coupling implies that splicing occurs co-transcriptionally 
(i.e., during transcription). However, this process can also take place post-
transcriptionally (i.e., after transcription). Ten years have passed since the co-
transcriptional splicing of pre-mRNAs, with a particular emphasis on the connections 
between transcriptional elongation and splicing, was last thoroughly discussed in this 
forum (Goldstrohm et al., 2001b). Since then, excellent reviews covering specific 
aspects of the coupling of transcription and alternative splicing have been published (for 
recent reviews see (Moore and Proudfoot, 2009; Munoz et al., 2010; Oesterreich et al., 
2011)). In this review we aim to revisit current concepts and experimental observations, 
discuss the recent advances in the field, and highlight the major unanswered questions 
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regarding the functional coupling of RNAPII transcription and pre-mRNA alternative 
splicing. 
 
The regulation of alternative splicing: general arguments for functional coupling 
The predominant form of the spliceosome (the U2-spliceosome or “major 
spliceosome”) is composed of a core of five snRNPs, termed U1, U2, U4, U5, and U6, 
and an additional estimated number of ~ 200 protein factors (Kramer, 1996; Wahl et al., 
2009). Numerous in vitro and in vivo studies support the model that spliceosome 
assembly occurs in an ordered step-wise manner (Will and Luhrmann, 2001; 
Gornemann et al., 2005; Matlin and Moore, 2007; Wahl et al., 2009; Huranova et al., 
2010; Hoskins et al., 2011). This unidirectional multistep assembly initially reflects the 
orderly recognition of the primary cis sequence elements that define the exon/intron 
boundaries (the 5‟ and 3‟ splice sites) and the associated 3‟ sequences for intron 
excision (the polypyrimidine (Py) tract, and the branch point sequence (BPS)). The first 
stable complex formed during the assembly of the spliceosome is the early spliceosome 
complex (E), also known as the commitment complex. In this step, the 5‟ splice site of 
the intron is bound by the U1snRNP, and the splicing factors SF1 and U2AF 
cooperatively recognize the BPS, the Py, and the 3‟ splice site (Berglund et al., 1997; 
Berglund et al., 1998). These two factors promote the recruitment of the U2snRNP to 
the branch point in an ATP-dependent manner to form complex A (MacMillan et al., 
1994). Complex B is formed by the subsequent binding of the U4/U6-U5 tri-snRNP. 
After RNA-RNA and RNA-protein rearrangements at the heart of the spliceosome, U1 
and U4 are released. The release of U1 and U4 produces the C (or catalytic) complex 
that is ultimately responsible for catalyzing the intron excision and exon-exon ligation 
reactions (Fig. 1A).  
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Alternative exons, as opposed to constitutive exons, can be alternatively spliced to give 
rise to two or more mRNAs from a single pre-mRNA. Interestingly, an essential 
property of the genome sequence of eukaryotes (especially in higher eukaryotes) is the 
suboptimal arrangement and poor conservation of the core cis-elements that drive the 
recruitment of the spliceosome (Izquierdo and Valcarcel, 2006; Mendes Soares and 
Valcarcel, 2006). This “loose” or suboptimal recognition of splicing signals in 
alternative exonic/intronic sequences is critical because it renders the sequences 
sensitive to the combinatorial regulation exerted by different elements, including 
transcription-coupled alternative splicing regulation. Additional cis elements, known as 
exonic and intronic splicing silencers or enhancers (ISS, ISE, ESS, and ESE), 
participate in the regulation of alternative splicing. These elements are most often 
recognized and acted on by specific RNA-binding proteins that include heterogeneous 
nuclear ribonucleoproteins (hnRNPs) and serine/arginine-rich (SR) proteins (Wu and 
Maniatis, 1993) (Fig. 1B). These positive and negative regulators together with an ever-
increasing number of additional auxiliary regulators, act on a given alternatively 
processed pre-mRNA sequence as defined by the “splicing code”. This “splicing code” 
is still incompletely characterized, and it is highly contextual in nature, varying among 
different tissues and distinct homeostatic environments (Zhang et al.; Lin and Fu, 2007; 
Barash et al., 2010). 
Initial work supporting the existence of co-transcriptional splicing comes from direct 
observation. Electron microscopy has shown that intron lariat formation and/or the 
removal of intronic sequences can occur in nascent transcripts that are still tethered to 
their DNA templates (Beyer and Osheim, 1988; Osheim et al., 1988). Several high-
resolution light microscopy studies using RNA-FISH probes to specifically discriminate 
between unprocessed and processed mRNA species revealed that in a significant 
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proportion of genes, either endogenous or transiently expressed synthetic reporter 
constructs, the processing of intronic sequences was performed at or very close to the 
active template gene (Johnson et al., 2000; Custodio et al., 2004). Analogous “direct” 
observation of co-transcriptional pre-mRNA processing has been achieved by 
comparing the patterns observed in nascent chromatin-associated RNA with those found 
after the release of the RNA into the nucleoplasm (Pandya-Jones and Black, 2009). 
Other more indirect approaches have also provided support for a model of co-
transcriptional processing for the vast majority of intronic sequences. For example: (1) 
multiple components of the spliceosome physically interact with the transcription 
apparatus and components of the chromatin environment, including modified histones 
(see below); (2) ChIP analysis suggests a highly conserved stepwise assembly of 
spliceosomal subunits on the chromatin template (Listerman et al., 2006); (3) 
measurement of the rates of RNAPII transcription and pre-mRNA splicing in vivo on 
endogenous human genes show that splicing occurs long before the ends of the gens are 
transcribed (Singh and Padgett, 2009), and (4) co-transcriptional pre-mRNA processing 
can be reproduced in vitro in an RNAPII-specific manner (Natalizio and Garcia-Blanco, 
2005) (Das et al., 2006; Yu et al., 2010). Consistent with these findings, total RNA 
sequencing reveals widespread co-transcriptional splicing in the human brain (Ameur et 
al., 2011). Similarly, measurements of complete and incomplete splicing rates through 
the analysis of genome-wide RNAseq datasets in various sub-cellular fractions is 
consistent with widespread co-transcriptional splicing in humans (H. Tilgner, R. Guigo, 
and the ENCODE CONSORTIUM, personal communication). 
Based on these observations, it was initially thought that the physical coupling of 
transcription and downstream maturation events was a constitutive and intrinsic 
property of the machinery involved in these phenomena and that this coupling was 
 8 
therefore not necessarily subject to regulation. Early models depicted the spliceosome as 
being optimally assembled when recruited co-transcriptionally to a ternary complex 
composed of the RNAPII holoenzyme, the chromatin template, and the nascent 
transcript. This view prompted pioneering in vitro studies demonstrating that indeed, 
RNAPII-associated co-transcriptional pre-mRNA constitutive splicing is significantly 
more efficient than the uncoupled processing of a purified, pre-transcribed template or 
the processing of a transcript that is being synthesized by an enzyme that cannot couple 
with the spliceosome, such as the T7 phage RNA polymerase (Natalizio and Garcia-
Blanco, 2005; Hicks et al., 2006; Das et al., 2007). It is worth noting that these in vitro 
co-transcriptional models required an intact RNAPII CTD, but the addition of a 
complete CTD to the T7 polymerase did not confer enhanced co-transcriptional 
processing (Natalizio et al., 2009). However, we know that some pre-mRNA sequences 
are spliced after the release of the transcript depending on the position of the intron 
(Bauren and Wieslander, 1994; Pandya-Jones and Black, 2009). In some cases, splicing 
occurs significantly far away from the chromatin template (Johnson et al., 2000). 
Recently published work reporting the real-time visualization of intron removal in live 
mammalian cells has revealed that although constitutive introns are indeed co-
transcriptionally removed, there are some particular cases where processing is delayed 
until after transcription has been completed (Vargas et al., 2011). This result most likely 
reflects some regulatory effects on gene expression programs. Thus, splicing may occur 
after transcription is completed and co-transcriptional splicing is not obligatory but is 
rather a general rule with exceptions. 
Although it is generally accepted that the physical co-occurrence of transcription and 
splicing favors both processes, it is also likely that physical coupling is not absolutely 
required for either process. Rather, co-transcriptional processing is predominantly 
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regarded as a widespread property of a significant share of intronic sequences. Co-
transcription allows the development of multiple mechanisms that exquisitely co-
regulate pre-mRNA synthesis and alternative processing. We use the phrase “functional 
coupling” to refer to the mutual influence of transcription and pre-mRNA splicing on 
one another. The functional coupling of transcription and pre-mRNA processing 
appears to be a major element in the regulation of gene expression programs, driving 
complex cell functions such as tissue-specific differentiation and development (Barboric 
et al., 2009) and the integration of DNA damage signaling and apoptosis (see below). 
The immediate question is: which molecular mechanisms drive these functional 
coupling events? As we will see in the following sections, the functional coupling of 
transcription and alternative splicing is largely based on the shared properties of 
alternative splicing-regulatory sequences and their derived regulatory mechanisms. The 
available data show that transcription influences alternative splicing by recruiting 
positive and negative regulators to the nascent pre-mRNA (“physical coupling”) or by 
presenting a specific sequence context to the spliceosome by altering the synthesis rate 
of the nascent transcript (“kinetic coupling”). These two pathways, which are proposed 
to explain the link between transcription and splicing, are distinct but not mutually 
exclusive models. 
 
Physical coupling: interactions between the transcription and splicing machineries 
One mechanism that may explain the functional coupling between transcription and 
splicing is the establishment of physical interactions among components of both 
machineries. Many examples of these interactions have been described throughout the 
literature (see below), and components of these macromolecular complexes have been 
purified using a variety of approaches. These interactions are also believed to underlie 
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regulatory mechanisms shared by both processes, such as post-translational 
modifications that transduce signaling cues or the reading of chromatin marks (Sims et 
al., 2007; Lenasi and Barboric, 2010). 
It is believed that the carboxyl terminal domain (CTD) of the large subunit of RNAPII 
plays a major role in the co-transcriptional coupling of RNA biogenesis and processing. 
The CTD is comprised of 52 tandem repeats in mammals (26 in yeast) of the 
heptapeptide YSPTSPS, with a heterogeneous degree of degeneration. The CTD 
constitutes an extremely versatile and flexible platform for the recruitment of factors to 
the nascent transcript. This recruitment promotes the co-transcriptional accomplishment 
of gene expression-related functions, ranging from pre-mRNA capping, 3‟-end 
processing and excision, pre-mRNA splicing, and chromatin remodeling (Phatnani and 
Greenleaf, 2006). 
Specific residues within this repeat are targeted for post-translational modifications in a 
differential manner that depends on the stage of transcription. The modification of the 
CTD is believed to constitute an extremely versatile mechanism for encoding and 
transducing information about the functional status of the transcription complex to the 
different gene expression machineries. Dynamic changes in post-transcriptional 
modifications generate a “CTD code” (Fig. 2) that contributes to the recruitment and 
release of processing factors at specific stages of transcription (Komarnitsky, 2000; 
Buratowski, 2003; Egloff and Murphy, 2008). Hypophosphorylated RNAPII assembles 
into pre-initiation complexes positioned at gene promoters, whereas 
hyperphosphorylated RNAPII associates with the elongation stage. Cyclin-dependent 
kinase 7 (CDK7), which is part of the general transcription factor IIH (TFIIH), is 
responsible for the phosphorylation of Ser5. This modification has been linked with 
transcription initiation and is preferentially associated with the 5‟-end of the genes. Ser2 
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phosphorylation by CDK9, the catalytic subunit of the positive transcription elongation 
factor (P-TEFb), is associated with the 3‟-end of the genes. Classically, P-TEFb was 
thought to be the sole CTD kinase responsible for the conversion of RNAPII into its 
processive elongating form; however, recent studies have shown that Drosophila 
CDK12 and human CDK12 and CDK13 are also Ser2-CTD kinases (Bartkowiak et al., 
2010). These results impact our understanding of CDK9/CTD phosphorylation and open 
the door to revisions of the current model on CTD phosphorylation and transcriptional 
elongation. Other residues within the consensus heptapeptide are substrates for 
phosphorylation, including threonine, tyrosine, and the less conserved Ser7 (Zhang and 
Corden, 1991; Baskaran et al., 1993; Zhou et al., 2009; Hsin et al., 2011). Recent 
genome-wide analysis in yeast detected Ser7 phosphorylation at the 5‟-ends of genes 
and in introns, suggesting that Ser7 marks could facilitate elongation and splicing (Kim 
et al., 2010; Tietjen et al., 2010). Glycosylation, methylation, ubiquitylation and proline 
isomerization of residues within the CTD have also been reported (Kelly et al., 1993; 
Morris et al., 1999; Li et al., 2007b; Sims et al., 2011). 
Evidence that the CTD is required for splicing has been observed both in vivo and in 
vitro. Truncation of the CTD reduces splicing efficiency in vivo (McCracken et al., 
1997; Fong et al., 2003; Rosonina and Blencowe, 2004). The transcriptional activation 
of RNAPII-dependent genes induces the spatial recruitment of splicing factors to the 
transcription site, and this reaction is dependent on the integrity of the CTD (Du, 1997; 
Misteli, 1999). In vitro assays have shown that purified hyperphosphorylated RNAPII is 
able to activate pre-mRNA splicing, but hypophosphorylated RNAPII can inhibit 
splicing (Hirose, 1999). Finally, recombinant CTD can also stimulate the splicing 
reaction in vitro. However, this finding is only valid in the context of exon definition, 
when both the 3‟ and 5‟ splice sites are accessible (Zeng and Berget, 2000). 
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Despite the significant efforts focused on the characterization of the CTD, the specific 
role of the CTD in the regulation of splicing is not completely understood. The role of 
the CTD is likely to be variable and context-specific, and probably depends on the 
subset of effectors and/or regulators recruited in each condition. In some cases, RNAPII 
may not be sufficient for splicing factor accumulation and instead a more complex and 
dynamic mechanism for recruitment that involve direct interactions with the nascent 
RNAs may occur (Kotovic et al., 2003; Gornemann et al., 2005; Lacadie and Rosbash, 
2005; Listerman et al., 2006; Das et al., 2007). It has been surmised that “scaffolding”, 
adaptor or bifunctional proteins may regulate the functional coupling of transcription 
and splicing in a manner similar to the specification of signaling pathways in other cell 
systems. Indeed, some nuclear factors, also known as “cross-talk” factors or “coupling 
mediators” interact with both the transcription and splicing machineries. These nuclear 
factors have therefore been proposed to regulate the physical coupling of the two 
processes. Although their differential features are significant, these nuclear factors all 
share the following properties: first, they are capable of physically interacting with 
components of both the RNAPII transcription apparatus and the spliceosome, mostly 
through the CTD of RNAPII. In fact, the specific recognition of hyperphosphorylated 
forms of the CTD is currently regarded as a significant feature supporting the putative 
role of a given factor on co-transcriptional pre-mRNA processing. Second, these forms 
contain multiple protein-protein interaction domains or motifs, which confer the 
potential ability to act as scaffolding elements. Third, these factors are capable, at least 
under specific experimental conditions, of modulating transcription, splicing, or both 
(Kornblihtt et al., 2004; Allemand et al., 2008). 
Transcription-splicing coupling factors 
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The family of serine/arginine rich-proteins (SR proteins) includes several conserved 
RNA-binding factors that have been primarily characterized as splicing regulators, 
although they seem to play a role in several other mRNA metabolism processes such as 
nucleocytoplasmic export and translation. The activity of SR proteins is tightly 
regulated through several mechanisms, including tissue-specific differential expression, 
signal-dependent phosphorylation, subnuclear distribution and conditional competition 
with other factors (for an extensive discussion of different aspects of these proteins, 
please refer to (Lin and Fu, 2007)). Physical interactions between SR proteins and the 
CTD of RNAPII have been reported, but the functional relevance of this association is 
not yet known (Yuryev et al., 1996; Bourquin et al., 1997). Indeed, this association was 
proposed to be required for the appropriate regulation of the recruitment of SR proteins 
from specific subnuclear structures called nuclear speckles to transcriptionally active 
sites (Misteli, 1999). SR proteins have been found to co-purify with the RNAPII 
holoenzyme (Das et al., 2007). Moreover, SR proteins partially mediate the 
enhancement of in vitro co-transcriptional pre-mRNA processing presumably by 
facilitating the recruitment and assembly of the early spliceosome on nascent RNAPII 
transcripts (Das et al., 2006 and 2007). The elongation-dependent influence of some of 
these factors, including SRp20 and SRSF1 (formerly called SF2/ASF), on specific 
alternative splicing minigene models has been shown to be dependent on the integrity of 
the RNAPII CTD as well as its phosphorylation state (de la Mata and Kornblihtt, 2006; 
Barboric et al., 2009). In cells, the depletion of the essential splicing factor SC35 led to 
a diminished recruitment of P-TEFb to the RNAPII complex and, consequently, a lower 
CTD phosphorylation level and increased accumulation of the RNAPII large subunit on 
the 5‟ ends of genes, both of which are hallmarks of impaired elongation (Lin et al., 
2008). The specific mechanisms by which SR proteins establish the functional coupling 
 14 
between transcription and alternative splicing are not yet completely understood. 
However, interactions involving both the co-transcriptional assembly of pre-
spliceosomal complexes and the regulation of the progression towards an elongation-
competent state by the RNAPII complex are likely to be important in this regulation. 
Other splicing factors participate in the functional coupling of transcriptional elongation 
and alternative splicing. The splicing factor SKIP interacts with PTEF-b and positively 
influences transcription elongation by the HIV-1 Tat activator (Bres et al., 2005). Tat-
SF1, the mammalian homolog of the yeast U2 snRNP component CUS1, has also been 
proposed to mediate the splicing-dependent regulation of transcription elongation in 
vitro (Fong and Zhou, 2001; Maniatis and Reed, 2002). 
An interesting group of factors has been shown to play dual roles both in transcription 
and splicing regulation and/or to physically interact with components of both the 
splicing and transcription machinery. These factors include, among others, PSF, 
p54nrb/NonO, Prp40, FBP11, and TCERG1. Some of these factors contain tandem 
repeats of WW (Chan, 1996) and FF (Bedford and Leder, 1999) domains; this feature 
might define a subset of potential coupling factors. 
PSF and p54
nrb
/NonO are two RRM domain-containing proteins that are ubiquitously 
expressed in human tissues. These proteins share 71% identity over a 320-amino-acid 
region encompassing their RNA recognition motif (RRM) (Dong et al., 1993). 
Intriguingly, these proteins have been found to interact with each other through their 
RRM domains, although the functional consequences of this interaction are not known 
(Peng et al., 2002). PSF and p54
nrb
/NonO interact with either hypophosphorylated or 
hyperphosphorylated forms of the RNAPII CTD (Emili et al., 2002). It has been shown 
that p54
nrb
/NonO associates with 5‟ splice sites in high molecular weight complexes 
containing the U1 and U2 snRNPs and mostly (but not exclusively) phosphorylated 
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forms of RNAPII, both in vitro and in vivo (Kameoka, 2004). Similarly, PSF can be 
found in higher-order complexes assembled in vitro that contain all of the spliceosomal 
subunits (Peng et al., 2006). The fact that PSF was found to interact with the 
hypophosphorylated forms of the RNAPII and spliceosomal components involved in the 
5‟ splice site is particularly interesting given that hypophosphorylated RNAPII is 
detected in the paraspeckle nuclear compartment. Moreover, PSF is enriched at 
paraspeckles, and mass spectrometry analysis of hypophosphorylated RNAPII 
complexes isolated both U1 snRNP proteins and SR proteins (Fox et al., 2005; Das et 
al., 2007; Fox and Lamond, 2010). Based on these data, it is tempting to speculate that 
PSF may prime interactions between the transcription initiation complex and the early 
spliceosome. Furthermore, the paraspeckle region might be the location at which these 
events take place. Consistent with these observations, in vivo experiments suggest that 
the PSF is capable of mediating transcription activator-dependent stimulation of pre-
mRNA processing through its binding to the CTD of RNAPII (Rosonina et al., 2005). 
The yeast splicing factor Prp40 contains two WW domains followed by four FF domain 
repeats, and it was first characterized as a splicing regulator. Prp40 is an essential U1 
snRNP-associated protein that participates as a scaffold in the earlier steps of 
spliceosome complex formation (Kao and Siliciano, 1996). The WW domains of Prp40 
recognize the consensus sequence PPXY in BBP, which is the yeast ortholog of the 
splicing factor SF1. BBP interacts directly with Mud2p, which is the yeast homolog of 
human U2AF
65
, which binds to the polypyrimidine region at the 3‟-end of introns. 
Based on these interactions, it has been proposed that Prp40 helps to define a bridging 
interaction that links both ends of the intron (Abovich and Rosbash, 1997). Prp40 also 
binds to the yeast U5-associated protein Prp8. Therefore, Prp40 might contribute to the 
recruitment of the U5 snRNP to the early spliceosome during cross-intron bridging. 
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According to the currently prevailing sequential model, this interaction may destabilize 
U1 snRNP binding, allowing for the progression towards a mature spliceosome 
(Abovich and Rosbash, 1997). Intriguingly, a recent study demonstrated that, in the 
absence of the WW domains of Prp40, no defects in in vivo splicing, in vivo U1 or U2 
snRNP recruitment, or in vitro early splicing complex assembly were detected 
(Gornemann et al., 2011). Moreover, the Prp40 WW domains were dispensable for 
yeast viability. Delays in U5snRNP recruitment and altered spliceosome formation in 
vitro did not prevent spliceosome maturation or changes in RNAPII distribution along 
the transcripts. One plausible explanation that may reconcile these apparently opposing 
observations is that the Prp40 WW domains are required to act as a scaffold for early 
spliceosome assembly in only a subset of genes or in specific functional contexts. 
Finally, Prp40 was the first splicing factor that was shown to bind the phosphorylated 
CTD of RNAPII via its WW domains (Morris and Greenleaf, 2000). 
There are two putative mammalian orthologs of Prp40, FBP11 and HYPC. FBP11, also 
known as HYPA or Prpf40A, comprises two WW and six FF domains. Similar to yeast 
Prp40, FBP11 interacts with SF1 and U2AF
65
, which suggests that it may play a role in 
the recognition of the 3‟-end of introns (Lin et al., 2004), However, unlike Prp40, 
FBP11 has not been strictly characterized as a component of the U1snRNP. Structural 
characterization of the binding mechanism and involved surfaces in the FF domain-
containing region of FBP11 revealed that FBP11 is able to recognize phosphorylated 
sequences such as the CTD of RNAPII (Allen et al., 2002). Intriguingly, this interaction 
is preferentially established by the FF1 repeat, whereas Prp40 interacts weakly with the 
phosphorylated CTD through its FF2 repeat (Gasch et al., 2006). This observation 
illustrates that this family of factors displays significant differences regarding the 
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binding specificity of their WW and FF domains despite their apparent structural 
conservation. 
HYPC, also known as Prpf40B, is the least well characterized of the putative 
mammalian Prp40 orthologs. It has an analogous modular structure of two WW 
domains and four FF domains. HYPC, as well as FBP11, has been implicated in the 
pathogenesis of neurological disorders, including Huntington‟s disease and Rett 
syndrome (Faber et al., 1998; Passani et al., 2000; Buschdorf and Stratling, 2004). 
High-resolution confocal microscopy analysis revealed that HYPC shows a precise 
overlap with SC35 in the splicing factor-rich nuclear speckles (S. Becerra and C. Suñé, 
unpublished data), which suggests that HYPC is involved in pre-mRNA processing. 
FBP21 is the only member of the family of potential coupling factors that lacks FF 
domain repeats. However, similarities between its WW domains and the interdomain 
spacer length and those of the above-mentioned Prp40 paralogs indicate that FBP21 
might play a conserved role in splicing as well. This theory is supported by data 
showing that FBP21 interacts with the U1 snRNP protein U1C, the core snRNP proteins 
SmB and SmB', and the branchpoint binding protein SF1, suggesting that FBP21 may 
play a role in the cross-intron bridging of U1 and U2 snRNPs in the mammalian A 
complex (Bedford et al., 1998). Importantly, the WW domains of FBP21 are critical for 
its splicing activator function and for its interaction with SIPP1 (Huang et al., 2009), a 
splicing factor that associates with polyglutamine-tract-binding protein (PQBP1) and 
protein phosphatase 1 (PP1). 
TCERG1, also known as CA150, is a nuclear protein that has been implicated in 
transcriptional elongation and pre-mRNA splicing. TCERG1 contains three WW 
domains in its amino-terminal half and six FF repeat domains in its carboxyl-terminal 
half (Suñé et al., 1997) and associates with hyperphosphorylated RNAPII and with 
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transcriptional elongation and splicing components through both its WW and FF 
domains (Goldstrohm et al., 2001a; Lin, 2004; Smith et al., 2004; Sanchez-Alvarez et 
al., 2006). TCERG1 has been identified in highly purified spliceosome fractions 
(Neubauer et al., 1998; Makarov et al., 2002; Rappsilber et al., 2002; Deckert et al., 
2006). TCERG1 localizes at the interface of nuclear speckles and what are presumably 
nearby transcription sites (Sanchez-Alvarez et al., 2006). Several studies have 
demonstrated that TCERG1 can affect the splicing of several splicing reporters (Carty et 
al., 2000; Lin, 2004; Cheng et al., 2007; Pearson et al., 2008; Sánchez-Álvarez et al., 
2010) and of putative cellular targets identified by microarray analysis following 
TCERG1 knockdown (Pearson et al., 2008). Given these data, TCERG1 has been 
observed as a possible factor in coordinating transcriptional elongation and splicing, a 
suggestion that was in fact proposed in the first Gene review on co-transcriptional 
splicing (Goldstrohm et al., 2001b) (see below). Like other members of this family of 
proteins, TCERG1 has been implicated in the pathogenesis of neurodegenerative 
diseases (Holbert, 2001; Arango et al., 2006; Andresen et al., 2007). 
 
Kinetic coupling: how elongation rate affects splice site choice 
RNAPII transcription initiation and pre-initiation complex assembly were initially 
described as the rate-limiting steps of transcriptional activation. However, 
transcriptional elongation is also a very highly regulated process. Numerous genes have 
been shown to be controlled at this stage, and a great variety of factors that affect this 
step of the transcription cycle have been identified (Sims et al., 2004). Increasing 
evidence shows that after promoter clearance, which depends on CTD phosphorylation, 
RNAPII stalls approximately 30-50 nucleotides downstream of the transcription start 
site. This promoter-proximal pause was first described for the Drosophila heat shock 
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genes and in the c-myc and HIV-1 genes (Bentley and Groudine, 1986; Kao et al., 1987; 
O'Brien and Lis, 1991; Krumm et al., 1992). More recent, genome-wide studies suggest 
that the promoter-proximal pause is a global tool for gene regulation (Core and Lis, 
2008; Nechaev and Adelman, 2008). The promoter-proximal pause has been proposed 
as a checkpoint to ensure that only correctly assembled RNAPII complexes continue 
elongating through the gene (Levine, 2011). Given that different splicing sites of a 
transcript are synthesized and co-transcriptionally exposed to the splicing machinery, it 
is then plausible that the RNAPII elongation rate might modulate alternative splicing. 
This “kinetic” regulation of alternative splicing model proposes that the transcriptional 
elongation rate is critical for the outcome of competing splicing reactions that occur co-
transcriptionally. Some authors have viewed this regulation as a „window of 
opportunity‟ (Perales and Bentley, 2009), referring to the period during which the 
spliceosome is able to functionally assemble at one splice site before it is subject to 
competition from a downstream splice site.  
The first evidence of this kinetic coupling came from a study by Eperon and colleagues, 
which showed that the rate of RNA synthesis could affect the secondary structure of the 
mRNA and, in turn, affect alternative splicing (Eperon et al., 1988). A similar 
mechanism of regulation was also suggested by experiments in which the insertion of an 
RNAPII pause site downstream of weak alternative splice sites caused a reduction in the 
amount of regulated exon skipping by delaying the synthesis of an inhibitory element 
(Roberts, 1998). These studies hinted that the rate of transcript synthesis itself could 
define the specific sequence context presented to the co-transcriptional processing 
machinery.  
One of the most studied experimental systems that largely (but not exclusively) fits this 
kinetic model and can be used to illustrate this model is that of the fibronectin extra 
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domain I (EDI). This exon is preceded by a rather weak or degenerate 3‟ splice site, 
which is best utilized when the processivity of RNAPII is low and the splicing 
machinery has sufficient time to recognize it as a splice site. When RNAPII processivity 
is high due to elements such as transcriptional coactivators, open chromatin states or 
strong upstream promoters, it is more likely that the weak splice site will be presented 
simultaneously with the downstream, strong 3‟ splice site. The strong 3‟ splice site can 
then outcompete the weak splice site, favoring the skipping of the regulated exon 
(Cramer et al., 1999; Kadener et al., 2001; Kadener et al., 2002; Nogues et al., 2002). 
Direct evidence supporting the kinetic model was obtained by the exogenous expression 
of RNAPII mutant proteins that exhibit intrinsically low processivity. In these elegant, 
seminal experiments, the RNAPII-dependent transcription of the cell was driven 
exclusively by different α-amanitin-resistant polymerases; invariably, the polymerases 
with intrinsically low processivity elicited greater inclusion of the EDI exon (de la Mata 
et al., 2003). Interestingly, one mutation, termed C4 (Coulter and Greenleaf, 1982), 
which provokes a decrease in the rate of the RNAPII processivity, was found to be 
associated with changes in the alternative splicing patterns of transcripts encoded by the 
Drosophila ultrabithorax gene, underscoring the potential physiological relevance of 
this phenomenon (de la Mata et al., 2003). 
These observations may reflect a more general mechanism. Bentley and coworkers 
reported several years ago that RNAPII is paused at both 5‟ and 3‟ ends of genes and 
that this pausing correlates with the recruitment of processing factors (Glover-Cutter et 
al., 2008). More recent studies using high-resolution ChIP methods, demonstrate the 
preferential accumulation of RNAPII at specific regions within the body of genes 
(Alexander et al., 2010; Carrillo Oesterreich et al., 2010). Similarly, global analysis of 
nascent transcripts in yeast have shown a peak of RNAPII accumulation within terminal 
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exons, located ~ 250 nt upstream of the poly(A) site (Carrillo Oesterreich et al., 2010). 
Pausing near the 3‟ end of introns that correlates with the recruitment of splicing factors 
has also been described in intron-containing genes (Alexander et al., 2010). Thus, it is 
proposed that transcriptional pausing is imposed by a regulatory checkpoint that is 
associated with co-transcriptional splicing (Alexander et al., 2010). Therefore, proteins 
acting at the interface of these processes (the “coupling factors”) would act as 
checkpoint factors to regulate co-transcriptional splicing. Strong data that may support 
this hypothesis have been reported in recent work showing that the putative coupling 
factor TCERG1 regulates the alternative splicing of the Bcl-x gene by modulating the 
rate of RNAPII transcriptional elongation (Montes et al., 2012). The authors of the 
aforementioned study speculate that TCERG1 modulates the elongation rate of RNAPII 
to relieve pausing, thereby acting as a checkpoint regulator to promote co-
transcriptional splicing. 
The kinetic coupling model could explain the accurate control of the alternative 
processing of very specific sequences through the tight control of RNAPII processivity 
at the boundaries of the region of interest. This scenario has been proposed for the 
alternatively spliced variable region of the CD44 gene, in which a subset of regulatory 
RNA-binding factors could participate in the local control of RNAPII through the 
chromatin remodeling factor SWI/SNF, which in turn determines the processing profile 
of the resulting transcripts (Batsche et al., 2006). SWI/SNF can also associate with 
nascent transcripts to regulate alternative pre-mRNA splicing (Tyagi et al., 2009). 
Generally, RNAPII pausing could be a way to ensure its optimal activity, especially 
when transcribing large, highly regulated genes (Gilchrist et al., 2010; Levine, 2011). 
Insufficient time spent at the pause site could therefore result in more error-prone 
transcription and the production of inadequately processed transcripts. 
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The influence of chromatin in the regulation of alternative splicing 
The fundamental unit of chromatin is the nucleosome, which is composed of DNA 
wrapped around an octamer of the four core histones (H3, H4, H2A, and H2B) and 
separated from its neighboring nucleosomes by linker DNA (Izban and Luse, 1991). 
The reversible modification of histones and the positioning of nucleosomes along the 
chromatin template regulate transcription (Orphanides and Reinberg, 2000; Hodges et 
al., 2009). This finding was, to some degree, expected. However, the existence of 
connections between chromatin state and splicing was rather unexpected. A link 
between chromatin and splicing was first suggested when different RNA products were 
obtained when studying transcription from a collection of adenovirus-based templates, 
with identical trans-acting factors (Adami and Babiss, 1991). These authors 
hypothesized that changes in elongation rate, transcriptional pauses, or the 
transcriptional machinery could affect splicing patterns. At the same time, it was 
reported that the distances between the 5‟ and 3‟ splice sites followed a periodic pattern 
resembling nucleosome phasing, suggesting that nucleosomes are positioned according 
to exon/intron boundaries and thus reflect connections between chromatin and splicing 
(Beckmann and Trifonov, 1991). Accumulating evidence supports these hypotheses: 
cell replication alters alternative splicing by favoring compact chromatin and slowing 
RNAPII processivity (Kadener et al., 2001); the inhibition of topoisomerase-I by 
camptothecin promotes RNAPII stalling, which favors the co-transcriptional 
recruitment of splicing factors (Listerman et al., 2006); SW1/SNF chromatin 
remodeling factors have been shown to promote the inclusion of a cluster of exons in 
the endogenous CD44 gene (Batsche et al., 2006) and to regulate the alternative pre-
mRNA processing of a specific subset of transcripts in Drosophila (Waldholm et al., 
 23 
2011); histone modifying enzymes interact with various components of the splicing 
machinery (Martinez et al., 2001; Ohkura et al., 2005; Gunderson and Johnson, 2009); 
and high-throughput sequencing-based techniques have revealed that nucleosome 
positioning and specific histone marks are significantly correlated with the intron/exon 
structure of genes, underlining the potential impact of chromatin structure on splicing 
(see below). 
Several recent studies have revealed a specific, genome-scale nucleosome occupancy 
pattern in exon-intron regions. High-throughput immunoprecipitation and sequencing of 
nucleosome-associated chromatin have provided evidence that nucleosomes are 
predominantly enriched in exons (Andersson et al., 2009; Schwartz et al., 2009; Spies et 
al., 2009; Tilgner et al., 2009). The preferential occupancy of nucleosomes on exons is 
independent of transcription because it is also observed in non-expressed genes (Tilgner 
et al., 2009). Exons have higher GC content compared to introns, and GC-enriched 
regions have been suggested to be preferred for the assembly of nucleosomes (Peckham 
et al., 2007). Therefore, some of these studies suggested a correlation between GC 
content and nucleosome occupancy. However, GC-richness is likely not the only factor 
that determines nucleosome patterning. Data obtained from bioinformatics studies 
strongly suggest a functional link between nucleosome occupancy and splicing.  
Notably, the average length of the DNA wrapped around a histone octamer is 147 
nucleotides in length, which is approximately the length of an average mammalian 
internal exon, suggesting a conserved role for the nucleosome in the exon definition 
process (Schwartz et al., 2009; Tilgner et al., 2009). Moreover, nucleosome density in 
exons correlates with splice site strength and the properties of flanking introns. The 
correlation is stronger in weak exons as well as in exons that are surrounded by long 
introns (Spies et al., 2009; Tilgner et al., 2009). Intriguingly, alternatively spliced exons 
 24 
are more enriched in nucleosomes than constitutively spliced exons (Schwartz et al., 
2009), and longer exons are more enriched in nucleosomes than shorter exons 
(Schwartz et al., 2009; Spies et al., 2009; Tilgner et al., 2009). These observations might 
suggest that exonic nucleosomes do not act as a mark for spliceosome recognition. 
Despite the discrepancies, these data strongly support a role for nucleosome patterning 
in the regulation of RNA splicing. In the absence of further experimental evidence, two 
non-mutually exclusive hypotheses have been proposed. First, nucleosomes may act as 
“speed-bumps” for RNAPII, which would affect transcription rates and in turn modulate 
alternative splicing through the kinetic model discussed above (Schwartz et al., 2009; 
Spies et al., 2009). Secondly, nucleosomes could interact with splicing factors during 
transcription or facilitate interactions between splicing factors during exon definition 
and other splicing assembly steps (Tilgner et al., 2009). Additional experiments are 
required to elucidate the mechanisms by which nucleosomes affect splicing.  
Histones are substrates for numerous post-translational modifications, and their N-
terminal tails are subjected to acetylation, methylation, phosphorylation, ubiquitylation 
or sumoylation (Kouzarides, 2007). Most of these modifications are reversible, and the 
enzymes responsible of their removal have been characterized extensively (Bannister et 
al., 2002; Goto et al., 2002; Sugiyama et al., 2002; Yang and Seto, 2007). The 
combinatorial and dynamic nature of the post-translational modifications of histones 
enables them to be an extremely versatile and complex combinatorial system. The 
“histone code” is capable of encoding vast amounts of information, which regulates the 
expression of the underlying DNA sequences, by affecting the recruitment, assembly 
and function of multiple nuclear complexes. 
Histone methylation, acetylation and phosphorylation have recently emerged as major 
splicing regulators. For example, treatment with deacetylase inhibitors has been shown 
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to affect the alternative splicing of several reporter and endogenous genes (Nogues et 
al., 2002; Hnilicova et al., 2011), and histone acetylation is important for co-
transcriptional spliceosome assembly (Gunderson and Johnson, 2009); histone H3 
phosphorylated on serine 10 releases SR proteins from chromatin during the cell cycle 
(Loomis et al., 2009); and histone H3 lysine 4 tri-methylation (H3K4me3) enhances the 
recruitment of spliceosomal components to gene units (Sims et al., 2007). These data 
support a model in which histone modifications actively participate in the coupling of 
transcription and splicing. However, further study is required to elucidate their 
functional impact in the cell and the extent to which these potential mechanisms 
function throughout the genome. 
Genome-wide analyses revealed specific histone modification patterns within exons and 
introns. One early study revealed that histone H3 lysine 36 tri-methylation (H3K36me3) 
was globally enriched in exons (Kolasinska-Zwierz et al., 2009). Parallel studies have 
identified additional chromatin modifications in exons and introns (Andersson et al., 
2009; Schwartz et al., 2009; Spies et al., 2009; Tilgner et al., 2009; Dhami et al., 2010; 
Huff et al., 2010; Luco et al., 2010). It remains controversial whether these marks 
reflect nucleosome occupancy within exons (Schwartz et al., 2009; Tilgner et al., 2009) 
or constitute independent, relevant patterns with an intrinsic functional significance 
(Kolasinska-Zwierz et al., 2009; Spies et al., 2009). In support of the latter hypothesis, 
the average enrichment landscape for the H3K36me3 mark is actually contradictory to 
that of nucleosome occupancy because H3K36me3 is more highly enriched in 
constitutive exons than in alternative exons. Importantly, the relative enrichment of a 
number of histone marks differs between intronic and exonic sequences. The 
enrichment of some of these modifications depends on the relative positioning of the 
exon within the gene. For example, histone H4 lysine 20 methylation (H4K20me1) and 
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histone H2B lysine 5 methylation (H2BK5me1) are found preferentially at exons 
located at the 5‟ end of genes. In contrast, H3K36me3 tends to accumulate at the 3‟ end 
of the gene (Hon et al., 2009). Other marks exhibit a relative enrichment throughout the 
body of a gene reflective of its activation state, such as the histone H3 lysine 27 tri-
methylation (H3K27me3), which is highly enriched at the exons of weakly expressed 
genes and at the introns of highly expressed genes (Dhami et al., 2010). These 
observations suggest that histone modifications play an active role in the regulation of 
alternative splicing because they constitute potentially informative hallmarks of the 
identity of an exon or an intron within a specific activation context (Fig. 3). 
How can chromatin labels modulate co-transcriptional alternative splicing? From our 
current knowledge, mainly gathered from the fields of transcription and genome 
maintenance, these post-translational modifications are recognized with a striking 
degree of specificity by highly specialized modules. Following recognition, these 
modifications either exert a direct influence on the gene expression machinery or, more 
often, play a role as adaptors or scaffolding molecules for different groups of effector 
complexes. This model seems to be valid for the regulation of alternative splicing 
through the control of histone marks. In a recent pioneering study based on the mutually 
exclusive alternative splicing of the exons IIIb and IIIc of the FGFR2 gene (Carstens et 
al., 2000), it was observed that the H3K36me3 and H3K4me1 modifications are 
enriched when exon IIIc is included, but H3K27me3 and H3K4me3 accumulate 
preferentially when exon IIIb inclusion is favored (Luco et al., 2010). In this 
experimental system of alternative splicing, the RNA binding protein PTB functions as 
a major regulator by reducing the inclusion of IIIb and favoring the inclusion of IIIc. 
The PTB effect is mediated by MRG15, an adaptor protein that specifically binds 
H3K36me3, which is relatively enriched in cell types that exhibit greater IIIc inclusion 
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(Luco et al., 2010). Detailed integrative studies merging the available information about 
the alternative splicing profiles elicited when manipulating PTB levels, the preferential 
genome-wide binding sites for PTB and the H3K36me3 landscape might further explain 
the specificity of these mechanisms for PTB-mediated alternative splicing regulation.  
DNA methylation has also been shown to be enriched in exonic regions, although it 
remains unknown how this modification affects the splicing outcome. Methylation 
could affect splicing in combination with other factors. For example, in the CD45 gene, 
DNA methylation inhibits the inclusion of exon 5, and this methylation pattern opposes 
that of CTCF, which promotes the inclusion of exon 5. Genome-wide data indicate that 
CTCF binding downstream of alternative exons correlates with local RNAPII 
accumulation, suggesting that chromatin structure affects alternative splicing by 
modulating the RNAPII elongation rate (Shukla et al., 2011). This finding is especially 
relevant because CTCF acts as a general chromatin organizer and may be involved in 
numerous chromatin-dependent molecular processes. It is an exciting possibility that 
methylation patterns, which fluctuate during development, might modulate tissue-
specific alternative splicing events through the differential recruitment of CTCF. 
Further studies are required to reveal whether other DNA binding proteins are involved 
in the regulation of alternative splicing through a similar mechanism.  
Overall, histone modifications may elicit the modulation of pre-mRNA alternative 
processing both through the control of RNAPII kinetics and the co-transcriptional 
recruitment of splicing regulators. Histone modifications regulate the conversion 
between „closed‟ (silent) and „open‟ (active) chromatin conformations (Li et al., 2007a; 
Lee et al., 2010). Histone modifications can thus potentially modulate alternative 
splicing choices by regulating the RNAPII elongation rate. Supporting this model, 
intragenic hyperacetylated chromatin induced after neuronal depolarization increases 
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the RNAPII elongation rate and favours exon skipping in the neural cell adhesion 
molecule (NCAM) pre-mRNA (Schor et al., 2009). However, modifications related to 
transcriptional repression induce exon inclusion (Saint-Andre et al., 2011). Furthermore, 
targeting intronic sequences with siRNAs generates a closed chromatin context enriched 
in heterochromatin marks, blocking RNAPII elongation and affecting the splicing 
outcome (Allo et al., 2009). 
Recent data demonstrate that splicing can also modulate histone modification. Splicing 
activation enhances the recruitment of methyltransferase HYPB/Setd2 and the 
subsequent methylation of histone H3 at lysine 36 (H3K36me3) (de Almeida et al., 
2011), and splicing inhibition through splice site mutations or spliceostatin A (SSA) 
treatment produces a redistribution of H3K36me3 towards the 3‟ end of the gene (Kim 
et al., 2011). These data again suggest extensive bidirectional communication between 
epigenetic marks and splicing regulation. The characterization of genome-wide RNAPII 
elongation profiles compared with global alternative splicing programs and the 
distribution of the different histone marks will shed light on the functional relevance of 
these mechanisms in the regulation of gene expression. 
 
Functional impact of the coupling between transcription and splicing 
The functional coupling of transcription and alternative splicing provides a number of 
potential advantages when implemented in a given gene expression program. The first 
aspect promoted by co-transcriptional pre-mRNA processing is the coordination of 
these two simultaneous mechanisms of control, enabling the specification of a 
transcriptional regulation program that is tailored to each splicing isoform and 
increasing the available possibilities to correctly tune gene expression. The functional 
coordination of transcription and splicing is a mechanism that would help to restrict a 
specific alternative processing pattern to the subpopulation or bulk of transcripts whose 
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synthesis is promoted by a transcriptionally driven response. Coupling would decrease 
the leakage of a specific alternative splicing mechanism beyond the time window during 
which the coupled transcriptional response of the cell is activated. Thus coupling would 
minimize gene expression noise while maximizing the efficiency of the whole process, 
as recently predicted using mathematical modeling approaches (Aitken et al., 2011; 
Kalsotra and Cooper, 2011). This aspect may be especially relevant to adaptive 
mechanisms based on regulatory switches that can radically affect cell fate, such as cell 
cycle or apoptosis control.  
The transitions between two distinct gene expression profiles that are associated with 
different contexts, such as consecutive developmental stages, are best implemented 
when the global coordinated regulation of the different involved mechanisms is ensured 
(Mendes Soares and Valcarcel, 2006; Keene, 2007; Kalsotra and Cooper, 2011). The 
coupling of transcription and post-transcriptional processing is likely essential for 
achieving this aim. Alternative splicing has been recently shown to influence the 
nonsense-mediated decay (NMD) and the usage of different 3‟ UTR stretches that in 
turn determine the miRNA sensitivity, subcellular localization, or stability of the 
resulting transcripts. Alternative splicing is extensively coupled to NMD because 
certain alternative exons introduce premature termination codons in their mature 
transcripts upon inclusion, and this can constitute a mechanism for diverting a subset of 
transcripts toward NMD-dependent degradation. A significant number of the targets of 
alternative splicing-determined NMD are splicing regulators themselves, potentially 
creating extensive arrays of regulatory feedback loops (Saltzman et al., 2008; Ip et al., 
2010). These findings might support the evolution of an intricate NMD-mediated 
feedback regulation of splicing factors to achieve a high degree of robustness in post-
transcriptional gene expression control, similar to what has been suggested for other 
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RNA-processing networks (Mittal et al., 2009). Importantly, NMD-eliciting alternative 
splicing events, which are overrepresented in RNA-binding protein-encoding genes, are 
affected by pharmacological treatments that alter RNAPII elongation (Ip et al., 2010) 
(see below). 
Coupling mechanisms also enable the establishment of checkpoints or quality controls 
that would promote each step of pre-mRNA synthesis and processing while ensuring the 
accomplishment of the essential preceding stages. One example is the significant 
influence of co-transcriptional pre-mRNA 5‟ capping on the establishment of processive 
elongation itself and vice versa (Schroeder et al., 2000; Moteki and Price, 2002). In a 
similar scenario, a highly processive elongation rate would elicit the recruitment of 
components of the splicing machinery and other pre-mRNA processing modules, such 
as 3‟ end processing complexes (Glover-Cutter et al., 2008). For a number of 
experimental models, the splicing components and the proximity of the splicing 
sequences to the 5‟ terminus of the gene or other regulatory sequences are required for, 
or at least significantly influence, the activity of the RNAPII complex (Fong and Zhou, 
2001; Lin et al., 2008). A potential function for this link is that splicing could be used as 
a quality checking mechanism in the control of transcription through a given gene. 
Although it does not fully overlap with the regulation of alternative splicing through co-
transcriptional coupling, it is probable that similar molecular events govern this reverse 
coupling. 
Another advantage of the functional coupling is the unification or simplification of the 
architecture of the signaling networks upstream of the coupled transcriptional and 
alternative splicing programs. The most intuitive example is represented by the 
proposed “kinetic model” of functional coupling: if the transcriptional elongation rate of 
RNAPII determines the alternative processing pattern of the transcripts, a single 
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signaling input primarily aimed at controlling the transcription of a given gene can also 
be used to specify the processing profile of the resulting transcripts. This option could 
be especially relevant in the case of regulatory programs that require rapid and efficient 
activation. As mentioned above, recent studies have demonstrated the widespread 
pausing or stalling of RNAPII complexes at gene promoters, relying on transcription 
elongation activation and release from pausing for induced expression (Muse et al., 
2007; Zeitlinger et al., 2007; Gilchrist et al., 2008; Adelman and Rogatsky, 2010; 
Gilchrist et al., 2010; Nechaev et al., 2010). Importantly, a number of these elongation-
driven genes encode regulators of stress-related responses, the innate immune response, 
and regulators of cell proliferation and apoptosis (Nechaev and Adelman, 2008; 
Adelman et al., 2009). Transcription elongation control during development may also 
be more important than previously thought (Levine, 2011). The production of a 
coherent alternative processing pattern that is regulated in part by transcription 
elongation control not only ensures the appropriate temporal coordination of 
transcription and splicing but also simplifies and equally prioritizes the triggering of the 
alternative splicing when necessary. The regulation of transcription-coupled alternative 
splicing seems to be deeply ingrained in the gene expression programs associated with 
such responses, including at least two different branches of the DNA damage response 
(DDR) and the regulation of apoptosis and cell cycle progression. 
The DDR encompasses a heterogeneous group of signaling pathways that have evolved 
to detect errors introduced in the genomic DNA by different exogenous or endogenous 
agents. The DDR triggers functional programs to avoid (1) the transmission of damage 
to the offspring cell population and (2) the disruption of essential processes, such as 
DNA replication. Alternative splicing is one target of the DDR (Katzenberger et al., 
2006; Matsuoka et al., 2007). To date, two different mechanisms that regulate different 
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control points of the DDR through transcription-coupled alternative splicing have been 
identified. One recent study identified a specific molecular and functional interaction 
between the Ewing Sarcoma EWS transcription factor and the stress-associated 
transcription factor YB-1. This interaction is essential for the appropriate co-
transcriptional recruitment of the spliceosome and thus for the timely inclusion of a 
number of alternative exons of the MDM2 gene (Dutertre et al., 2010). The full-length 
mRNA sequence yields a functional MDM2 protein, which is in turn capable of down-
regulating p53, one of the master regulators of DDR-triggered programs. Triggering a 
canonical DDR with different genotoxic agents, such as cisplatin and camptothecin, 
abrogated the interaction between EWS and YB-1. As a result, genome-wide alterations 
in the alternative splicing pattern of the transcriptome of the cell, including the splicing 
of the MDM2 gene, were observed. The mechanism of action of EWS/YB-1 in 
alternative splicing is currently poorly understood. Recently, EWS was found to interact 
co-transcriptionally with its target RNAs and to be redistributed to nucleoli upon UV 
light exposure (Paronetto et al., 2011). However, the molecular details of these 
regulatory mechanisms are currently unknown. Importantly, both inclusion and 
exclusion events were detected as specific consequences of camptothecin treatment, 
which suggests that an EWS/YB-1-based mechanism is unlikely to be the sole 
transcription-coupled effector of the DDR. 
A second potential mechanism that links DDR with transcription-coupled alternative 
splicing was proposed when analyzing RNAPII activity and alternative splicing in UV-
treated cells (Munoz et al., 2009). UV exposure elicits a significant global increase in 
the phosphorylation level of the RNAPII CTD, through an as yet not understood 
mechanism. Interestingly, UV exposure also elicits a decrease in RNAPII processivity 
on different gene templates. This change in processivity, in turn, influences pre-mRNA 
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processing, including that of two essential regulators of apoptosis, Bcl-x and caspase-9. 
This mechanism was found to be independent of other DNA damage signaling events, 
such as BRAD DNA damage-labeling proteins, ATM-dependent signaling, and p53-
dependent regulation. This mechanism could thus constitute a novel “pro-apoptotic 
checkpoint” in UV-mediated DNA damage and cell fate determination.  
The data discussed above link the functional coupling of transcription and splicing to 
the control of apoptosis-regulating networks. A number of genes that control apoptosis 
exhibit alternative splicing-driven functional switches (Akgul et al., 2004). A typical 
example is the Bcl-x gene, which encodes a master regulatory switch of apoptosis 
through the modulation of mitochondrial permeability. Alternative splicing yields the 
large, antiapoptotic isoform Bcl-xL or the short, proapoptotic regulator Bcl-xS upon the 
usage of two alternative 5‟ splice sites. An analogous example is Mcl-1, another Bcl-2 
family-related gene. A pioneering genome-wide siRNA survey for regulators of 
alternative splicing of both genes uncovered the extensive integration of cell cycle 
progression with these alternative splicing regulation events through aurora kinase A 
(AURKA) and SRSF1 (Moore et al., 2010). Suggesting a coherent, global apoptosis 
control pathway based on alternative splicing regulation, Bcl-x and Mcl-1 shared a large 
number of regulators with a disproportionate enrichment of alternative splicing and cell 
cycle regulators. Intriguingly, large subsets of RNAPII-dependent transcription 
regulators scored as positive modulators of the alternative splicing of Bcl-x, but not of 
Mcl-1. As mentioned before, the putative coupling factor TCERG1 has been shown to 
regulate alternative splicing of the Bcl-x gene by modulating the rate of RNAPII 
processivity (Montes et al., 2012). Regardless of the precise mechanisms underlying  
these differences, these data support an additional tuning mechanism specific for Bcl-x 
and other apoptosis-control genes, which would appropriately regulate apoptosis 
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sensitivity in different contexts. These observations lead to several interesting questions. 
(1) Why is the alternative splicing of Bcl-x, but not Mcl-1, functionally coupled to 
transcription control? (2) Is the transcription-coupled alternative splicing observed for 
Bcl-x related to the previously identified AURKA-SRSF1-driven, cell cycle-dependent 
axis? (3) What is the transcriptional coupling status for other apoptotic regulators that 
exhibit alternative splicing-dependent switches, such as Fas (Izquierdo et al., 2005; 
Bonnal et al., 2008)? 
To date, a small but rapidly growing number of studies have attempted to characterize 
global transcription-coupled alternative splicing profiles. A recently published study 
describes the transcriptome landscape in cells treated with either camptothecin or 5,6-
dichloro-1-β-D-furanosylbenzimidazole (DRB; a potent and specific inhibitor of the 
RNAPII CTD kinase CDK9). Both treatments inhibit RNAPII elongation and promote 
partially overlapping alternative splicing profiles. In both cases, enrichment for 
alternative splicing events associated with downstream NMD was noted, with a clear 
preference for splicing factor encoding-genes. The set of genes with alternative splicing 
patterns induced by camptothecin treatment were enriched in apoptosis-related and cell 
cycle-related genes, independently from RNA-binding proteins. These observations 
indicate that transcription-coupled alternative splicing likely depends on specific, 
conserved molecular mechanisms with functional significance. These observations also 
suggest that transcription-coupled alternative splicing (and most likely general 
alternative splicing) has been highly developed and evolutionary conserved in genes 
encoding RNA binding proteins and RNA splicing regulators. Alternative splicing in 
these genes most likely serves as a mechanism to regulate and ensure the robustness, 
stability and versatility of RNA-processing regulatory networks.  
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Importantly, these reports provide substantial data suggesting that uncoupled alternative 
splicing may be a significant component of the global regulation of downstream 
functions. Indeed, subsets of genes are found to either display changes only in their total 
transcript levels (regulation of transcription without significant change in splicing 
isoform) or changes in their alternative splicing (alternative splicing without apparent 
changes in transcriptional output). Similar observations have been reported by different 
surveys of global alternative splicing profiles associated with other biological 
mechanisms. These mechanisms include heart development (Kalsotra et al., 2008), 
neuron differentiation (Jelen et al., 2007; Ule and Darnell, 2007), or the triggering of 
specific major signaling routes, such as the insulin and wingless pathways (Hartmann et 
al., 2009). It must be noted that the transcriptome profiling in UV light-induced coupled 
alternative splicing regulation study discussed above (Munoz et al., 2009) also 
identified genes that are alternatively spliced but that are not affected at the level of 
expression. These genes represent approximately 15% of the total number of affected 
genes. However, it is conceivable that local changes in transcription elongation are 
capable of profoundly affecting the processing of a specific alternative exon but do not 
significantly (or detectably) impact the total output of that gene. Therefore, even in 
these documented models, transcription-dependent alternative splicing regulation may 
be more common than currently estimated. As discussed above, certain molecular 
mechanisms may have been implemented to attain precisely this localized effect on 
alternative splicing through transcriptional modulation without significantly affecting 
the total output of transcripts. Novel approaches exploiting unbiased, high-resolution 
technologies based on deep sequencing and integrative analysis with detailed 
information about RNAPII positioning, chromatin context and bioinformatics analysis 
of cis-features may help to further elucidate this question. 
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Concluding remarks 
The functional coupling of transcription and alternative splicing is emerging as an 
essential component of gene expression regulation. Despite considerable efforts, 
numerous questions remain regarding the functional significance and global impact of 
this coupling on cellular and organismal homeostasis as well as its underlying molecular 
mechanisms. High-throughput transcriptome profiling techniques are beginning to fill 
the gaps in our knowledge of the genes that undergo alternative processing. We are 
learning when and where this coupling is happening, and the co-transcriptional 
transcriptome is being characterized. A further step of considerable importance consists 
of the integrated analysis of these datasets together with information about the genome-
wide distribution of different forms of RNAPII, specific chromatin marks, and potential 
mediators of coupling. Due to its intrinsic potential as a mechanism for tissue-specific 
gene expression regulation, comparative analysis of co-transcriptional alternative 
splicing across distinct experimental models, such as panels of different cell lines, will 
also shed light on the global understanding of this exciting phenomenon. 
Last, but not least, the spatial organization of the eukaryotic genome within the nucleus 
is an additional layer of regulation to be taken into account.  Chromosomes are not 
randomly organized but occupy defined “territories” within the nucleus, and this 
distribution often results in the intermingling of specific subsets and combinations of 
genes that need to be co-regulated in a given situation (Branco and Pombo, 2006; 
Cavalli, 2007; Zhao et al., 2009; Sánchez-Álvarez et al., 2011). The functional coupling 
of transcription and pre-mRNA processing in the context of the highly 
compartmentalized eukaryotic nucleus still needs to be characterized. The recent 
purification and exhaustive analysis of the “transcription factory” (Melnik et al., 2011), 
the proposed structural unit for RNAPII transcription in the nucleus (Cook, 2010), will 
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substantially contribute to this goal. Notably, spliceosome components and associated 
factors were identified together with essential components of the RNAPII machinery as 
integral components of these higher-order structures (Melnik et al., 2011). It is also 
imperative to address the exact role of nuclear speckles in co- and post-transcriptional 
splicing. The recent observation showing the accumulation of intron-containing 
transcripts near these structures (Dias et al., 2010) has been strongly supported by 
single-molecule imaging studies, which revealed released unspliced pre-mRNA 
congregating around nuclear speckles (Vargas et al., 2011). This finding has important 
implications for our understanding of the mechanisms that regulate alternative splicing. 
This and other studies (Lionnet et al., 2010; Brody et al., 2011; Larson et al., 2011; 
Martins et al., 2011; Schmidt et al., 2011; Vargas et al., 2011; Gurskaya et al., 2012) 
that have used innovative microscopy and spectroscopy tools coupled with powerful 
statistical analyses and modeling allow us to monitor and quantify transcript biogenesis 
as well as co- and post-transcriptional processing at single-cell resolution in vivo. It is 
likely that, in the near future, numerous new insights and questions regarding the 
functional coordination of RNAPII transcriptional activity and pre-mRNA processing 
will continue to capture our attention. 
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Figure Legends 
 
Fig. 1. A. Schematic representation of spliceosome assembly and the splicing of a pre-
mRNA. The spliceosome is composed of a core of five small ribonucleoprotein particles 
(snRNPs), U1, U2, U4, U5, and U6, and ~ 200 additional proteins. The first step in 
spliceosome assembly is the formation of complex E (the commitment complex). The 5' 
splice site (GU, 5‟ss) is bound by the U1 snRNP, and the splicing factors SF1 and 
U2AF cooperatively recognize the branch point sequence (BP), the Py, and the 3‟ splice 
site (AG, 3‟ss). In an ATP-dependent manner, the pairing of the U2snRNP with the 
branchpoint results in the pre-spliceosomal complex A. Subsequent steps lead to the 
binding of the U4–U5–U6 tri-snRNP and the formation of the complex B. The catalytic 
complex C, which performs two trans-esterification reactions at the splice sites, is 
formed after rearrangements that detach the U1 and U4 snRNPs. These reactions result 
in the ligation of the exons and the excision of the intron, which is removed as the lariat 
RNA. B. Alternative splicing regulation by cis-elements and trans-acting factors. The 
core cis sequence elements that define the exon/intron boundaries (5‟ and 3‟ splice sites, 
GU-AG in red) and associated 3‟ sequences (polypyrimidine tract, Py; and branch point 
sequence, A) are poorly conserved. Additional enhancer and silencer elements in exons 
and in introns (ESE/ESS: exonic splicing enhancers/silencers, ISE/ISS: intronic splicing 
enhancers/silencers) add another layer of alternative splicing regulation. Trans-acting 
splicing factors, e.g., serine/arginine-rich (SR) family proteins and heterogeneous 
nuclear ribonucleoprotein particles (hnRNPs), bind to enhancers and silencers and 
interact with spliceosomal components. In general, SR proteins bound to enhancers 
facilitate exon recognition (green arrows) but hnRNPs inhibit this process (black 
arrows).  
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Fig. 2. The CTD-code and pre-mRNA processing. A. Hypophosphorylated RNAPII 
(IIa) is recruited to the preinitiation complex (PIC) at the promoter. B. Transcription is 
initiated upon the phosphorylation of the serines at position 5 (Ser5-P, green) and 
position 7 (Ser7-P, red) of the CTD by CDK7, the kinase component of the TFHII 
factor. Ser5-P helps to recruit the machinery necessary for the capping of the 5‟ end of 
the transcript (pink). C. During active elongation, the CTD is phosphorylated at Ser2 
(Ser2-P, blue) by CDK9 and CDK12/13 (see text for more details) to produce the 
hyperphosphorylated form of RNAPII (IIo). Numerous splicing factors are recruited to 
the hyperphosphorylated RNAPII (orange). D. During elongation towards the 3‟ end of 
the gene, Ser5 phosphorylation decreases by the action of Ser5-specific phosphatases. 
Polyadenylation and cleavage factors (blue) bind to the CTD to allow transcription 
termination and the release of the mature transcript. E. After dissociation from the DNA 
template, Ser2-specific phosphatases remove Ser5-P before recycling or reinitiation.  
 
Fig. 3. The role of chromatin in alternative splicing. A. Changes in chromatin 
organization due to the presence of chromatin remodeling factors (blue ovals), histone 
tail modifications (stars), or nucleosome positioning can affect the rate of RNAPII 
elongation and in turn affect the alternative splicing outcome. Slow elongation allows 
the binding of splicing factors to the nascent pre-mRNA and the recognition of weak 
splices sites, favoring exon inclusion (yellow box), while fast elongation favors exon 
exclusion (red box). B. Histone marks can also influence splicing decisions 
independently of the rate of RNAPII transcription by recruiting splicing factors via 
interaction with chromatin adaptors. 
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